Connection

Daniel Judge to Marfan Syndrome

This is a "connection" page, showing publications Daniel Judge has written about Marfan Syndrome.
Connection Strength

1.814
  1. Mitral valve disease in Marfan syndrome and related disorders. J Cardiovasc Transl Res. 2011 Dec; 4(6):741-7.
    View in: PubMed
    Score: 0.395
  2. Therapy of Marfan syndrome. Annu Rev Med. 2008; 59:43-59.
    View in: PubMed
    Score: 0.307
  3. Marfan's syndrome. Lancet. 2005 Dec 03; 366(9501):1965-76.
    View in: PubMed
    Score: 0.266
  4. A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome. Elife. 2015 10 27; 4.
    View in: PubMed
    Score: 0.132
  5. Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome. PLoS One. 2012; 7(9):e44639.
    View in: PubMed
    Score: 0.106
  6. Noncanonical TGF? signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science. 2011 Apr 15; 332(6027):358-61.
    View in: PubMed
    Score: 0.096
  7. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science. 2011 Apr 15; 332(6027):361-5.
    View in: PubMed
    Score: 0.096
  8. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med. 2008 Jun 26; 358(26):2787-95.
    View in: PubMed
    Score: 0.079
  9. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res. 2007 Aug 31; 101(5):512-22.
    View in: PubMed
    Score: 0.074
  10. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006 Apr 07; 312(5770):117-21.
    View in: PubMed
    Score: 0.068
  11. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 2004 Dec; 114(11):1586-92.
    View in: PubMed
    Score: 0.062
  12. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype? Hum Mol Genet. 2003 Sep 15; 12(18):2269-76.
    View in: PubMed
    Score: 0.056
  13. Characterization of microsatellite markers flanking FBN1: utility in the diagnostic evaluation for Marfan syndrome. Am J Med Genet. 2001 Feb 15; 99(1):39-47.
    View in: PubMed
    Score: 0.048
  14. A Pkd1-Fbn1 genetic interaction implicates TGF-? signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2014 Jan; 25(1):81-91.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.